The −482 C/T (rs2854117) and −455 T/C (rs2854116) polymorphisms of APOC3 are actively associated with non-alcoholic fatty liver disease (NAFLD) and insulin resistance (IR) (101). This evidence concerns the gene APOC3 and metabolic dysfunction-associated steatotic liver disease.